Fosdin Pack

Fosdin Pack Contraindications

calcium citrate + vitamin d3

alendronic acid




MedChoice Endocrine Group
Full Prescribing Info
Alendronic Acid: Except under special circumstances, alendronic acid should not be used when the following medical problems exist: Gastrointestinal diseases such as duodenitis, dysphagia, symptomatic gastroesophageal-reflux disease, pyrosis, gastritis, gastroesophageal reflux, hiatal hernia and peptic ulcer. Alendronic acid may exacerbate the symptoms.
Patients with a creatinine clearance lower than 35 mL per minute (0.58 mL/sec): alendronate is not recommended since its elimination may be reduced.
Hypersensitivity to alendronic acid.
Risk-benefit factors must be considered when the following medical problems exist: Hypocalcemia (primary or secondary) or vitamin D deficiency (alendronic acid may exacerbate these conditions). Hypocalcemia and Vitamin D deficiency must be corrected before starting therapy with alendronic acid.
Calcium citrate and Vitamin D3: Except under special circumstances this medication should not be used when the following problems exist: Hypercalcemia (primary or secondary), hypercalciuria, kidney calculus. There is a risk of exacerbation when taking this medication.
Sarcoidosis. It may potentiate hypercalcemia.
Risk-benefit factors must be considered when the following medical problems exist: Dehydration or electrolyte imbalance.
Chronic diarrhea or gastrointestinal malabsorption.
Patients with end stage renal failure may develop hypercalcemia when given calcium with meals. Serum calcium levels must be monitored during the dose adjustment period.
History of kidney stones.
Patients with idiosyncrasy and hypersensitivity to any component.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in